期刊文献+

不同血液透析方式对超敏心肌肌钙蛋白T水平的影响 被引量:2

Influences of Different Hemodialysis Methods on the Plasma Level of High Sensitive Cardiac Troponin T
下载PDF
导出
摘要 目的:探讨低通量透析(LF-HD)、高通量透析(HF-HD)及血液透析滤过(HDF)对血浆超敏心肌肌钙蛋白T(hs-c Tn T)水平的影响。方法:选取2015年7月-2016年2月在笔者所在医院血液净化中心进行长期透析的48例患者为研究对象(试验组),随机进行LF-HD、HF-HD及HDF治疗,并同期选取健康对照组30例。试验组患者每个透析治疗模式连续进行2周,3次/周,4 h/次;透析前后(间隔2周)分别检测hs-c Tn T水平,有效浓度根据血液浓缩进行校正。结果:经LF-HD后患者hs-c Tn T有升高趋势,但差异无统计学意义(P>0.05),合并心血管病患者经LF-HD后hs-c Tn T升高,差异有统计学意义(P=0.020)。经HF-HD及HDF治疗后患者hs-c Tn T水平均降低,差异均有统计学意义(P<0.05)。结论:血液透析患者在LF-HD后hs-c Tn T水平无明显变化,而HF-HD及HDF后hs-c Tn T水平明显降低,可以掩盖因急性心肌梗死引起的心脏生物标志物的增加。 Objective:To investigate the influences of low-flux hemodialysis(LF-HD),high-flux hemodialysis(HF-HD) and hemodialysis filtration(HDF) on the plasma level of high sensitive cardiac troponin T(hs-cTnT).Method:Forty-eight hemodialysis(HD) patients from July 2015 to February 2016 in our hospital were included in this design as the experimental group,who were randomized to start dialysis with LF-HD,HF-HD or HDF.Each mode of dialysis lasted two consecutive weeks,three times a week,4 hours of every dialysis.The plasma levels of hs-cTnT were measured before and after dialysis,the effective values were corrected for extent of ultrafiltration.Result:After the treatment of LF-HD,the hs-cTnT tended to increase but the difference was not statistically significant(P〉0.05),while the hs-cTnT levels increased significantly in patients with cardiovascular disease,the difference was statistically significant(P=0.020). The levels of hs-cTnT decreased significantly after the treatment of HF-HD and HDF,the differences were statistically significant(P〈0.05).Conclusion:Cardiac biomarker hs-cTnT levels had no statistically difference after LF-HD in HD patients,while the hs-cTnT levels decrease significantly after HF-HD and HDF, which can mask the increases of cardiac biomarker caused by myocardial infarction.
出处 《中外医学研究》 2016年第21期1-3,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 低通量透析 高通量透析 血液透析滤过 超敏心肌肌钙蛋白T Low-flux hemodialysis High-flux hemodialysis Hemodialysis filtration High sensitive cardiac troponin T
  • 相关文献

参考文献15

  • 1Khan N A, Hemmelgarn B R, Tonelli M, et al.Prognostic value oftroponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis[J].Circulation, 2005, 112(20): 3088-3096.
  • 2Sommerer C, Heckele S, Schwenger V, et al.Cardiac biomarkers are influenced by dialysis charaeteristics[J].Clin Nephrol, 2007, 68(6): 392- 400.
  • 3Madsen L H, Ladefoged S, Corell P, et al.N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis[J].Kidney Int, 2007, 71(6): 548-554.
  • 4Dautin G, Boudjeltia S, Soltani Z, et al.The changes in NT-proBNP plasma coneentrations during dialysis are highly dependent of the dialysis membrane uhrafiltration coefficient[J].Clin Chim Acta, 2007, 376(1-2): 237-239.
  • 5Bergstrom J, Wehle B.No change in corrected beta 2-mieroglobulin concentration after cuprophane haemodialysis[J].Lancet, 1987, 1(8533): 628-629.
  • 6Pianta T J, Horvath A R, Ellis V M, et al.Cardiac high-sensitivity troponin T measurement: a layer of complexity in managing haemodialysis patients[J].Nephrology (Carlton), 2012, 17(7): 636-641.
  • 7Assa S, Gansevoort R T, Westerhuis R, et al.Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients[J].Clin Res Cardiol, 2013, 102(6): 439-445.
  • 8Hill S A, Cleve R, Carlisle E, et al.Intra-individual variability in :roponin T concentration in dialysis patients[J].Clin Bioehem, 2009, $2(10-11): 991-995.
  • 9Bargnoux A S, Kuster N, Patrier L, et al.Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?[J].Clin Chem Lab Med, 2016, 54(4): 673-682.
  • 10Sandoval Y, Herzog C A, Love S A, et al.Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients[J].Clin Chem, 2016, 10(4) : 542-547.

同被引文献18

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部